# EDGAR Filing Document

**Accession Number:** 0001445283
**File Stem:** 0001193125-25-155004
**Filing Date:** 2025-7
**Character Count:** 3982
**Document Hash:** e91b715f4d814f4d0fae4b3df79cf6ca
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-25-155004.hdr.sgml**: 20250702

**ACCESSION NUMBER**: 0001193125-25-155004

**CONFORMED SUBMISSION TYPE**: 15-12G

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250702

**DATE AS OF CHANGE**: 20250702

**EFFECTIVENESS DATE**: 20250702

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KINETA, INC./DE
- **CENTRAL INDEX KEY:** 0001445283
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 15-12G
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37695
- **FILM NUMBER:** 251102185

**BUSINESS ADDRESS:**
- **STREET 1:** 7683 SE 27TH STREET
- **STREET 2:** SUITE 481
- **CITY:** MERCER ISLAND
- **STATE:** WA
- **ZIP:** 98040
- **BUSINESS PHONE:** (206) 378-0400

**MAIL ADDRESS:**
- **STREET 1:** 7683 SE 27TH STREET
- **STREET 2:** SUITE 481
- **CITY:** MERCER ISLAND
- **STATE:** WA
- **ZIP:** 98040

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** YUMANITY THERAPEUTICS, INC.
- **DATE OF NAME CHANGE:** 20201223

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PROTEOSTASIS THERAPEUTICS, INC.
- **DATE OF NAME CHANGE:** 20140813

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PROTEOSTASIS THERAPEUTICS INC
- **DATE OF NAME CHANGE:** 20080916

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**FORM 15** 

**CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION** 

**UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934** 

**OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)** 

**OF THE SECURITIES EXCHANGE ACT OF 1934.** 

**001-37695** 

**Commission File Number** 

## KINETA, INC.
**(By Kineta, LLC, as successor by merger to Kineta, Inc.)** 

**(Exact name of registrant as specified in its charter)** 

**c/o TuHURA Biosciences, Inc.** 

**10500 University Center Dr., Suite 110** 

**Tampa, Florida 33612** 

**(813) 875-6600** 

**(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)** 

**Common Stock, $0.001 par value per share** 

**(Title of each class of securities covered by this Form)** 

**None** 

**(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)** 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

---

| | |
|:---|:---|
|  Rule 12g-4(a)(1) | ☒ |
|  Rule 12g-4(a)(2) | ☐ |
|  Rule 12h-3(b)(1)(i) | ☒ |
|  Rule 12h-3(b)(1)(ii) | ☐ |
|  Rule 15d-6 | ☐ |
|  Rule 15d-22(b) | ☐ |

---

Approximate number of holders of record as of the certification or notice date: One\*

\* Explanatory Note: Effective as of June 30, 2025, pursuant to that certain Agreement and Plan of Merger, dated as of December 11, 2024, as amended on May 5, 2025, by and among TuHURA Biosciences, Inc. ("Parent"), Kineta, Inc. (the "Company"), Hura Merger Sub I, Inc. ("Merger Sub I"), Hura Merger Sub II, LLC ("Merger Sub II"), and the stockholders' representative, Merger Sub I merged with and into the Company (the "First Merger"), with the Company as the surviving corporation, and immediately following the First Merger, the surviving corporation merged with and into Merger Sub II, with Merger Sub II surviving as a wholly owned subsidiary of Parent under the name "Kineta, LLC". 

Pursuant to the requirements of the Securities Exchange Act of 1934, Kineta, LLC has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

---

| | | |
|:---|:---|:---|
|  Date: July 2, 2025 | **KINETA, LLC (as successor by merger to Kineta, Inc.)** | **KINETA, LLC (as successor by merger to Kineta, Inc.)** |
|  | By: | /s/ James A. Bianco, M.D. |
|  |  | James A. Bianco, M.D. |
|  |  | President |

---